phoneCall Now for a Free Case Evaluation - 800-611-7080

American Law Partners Advises Consumers to Remain Vigilant Despite Downplay of Fosamax Risks

(New York, NY, June 6, 2011) The American Law Partners, which represents clients with claims stemming from the severe side effects of the drug Fosamax, urges those individuals who have taken Fosamax to consult their physicians to determine their risk for femur fractures, even despite recent suggestions that potential risks are less than previously thought.
According to a post that appeared on the Web site of the American Council on Science and Health on June 1, “A new study should allay the fears of women who take osteoporosis drug. The Swedish study, just published in The New England Journal of Medicine, found that the class of drugs known as bisphosphonates (including Fosamax, Boniva, Actonel, Atelvia, and Reclast) caused only one atypical femoral fracture for every 2,000 people who used them in a year. While the risk of such fractures is indeed increased, to put the increase in proper perspective, study co-author Per Aspenberg likens the risk to that of being struck by lightning: On a sunny day, he says, the risk of being hit by lightning is close to zero. On a rainy day, the risk might be 1,000 times higher, but it’s still very small.”

The ACSH post continues: “The study’s findings are especially promising because of the size of the patient cohort, which included every Swedish woman aged 55 and up who’d had a femur (thighbone or hip) fracture in 2008. Within this group, researchers identified 59 whose fractures were atypical, 46 of whom had taken bisphosphonates – out of a total of over 83,000Swedish women who took the drugs that year. The fracture rate, then, was less than one in a thousand within that group. ACSH’s Dr. Gilbert Ross was happy to hear about the study results. ‘These unusual complications are extremely rare compared to the benefits,’ he says. ‘Hip fractures in particular are all too common among older white women with osteoporosis, and the consequences are often debilitating, even life-threatening.’”

While the American Law Partners is pleased to learn that the risk factor to the public is less than previously thought, the firm’s lawyers remain concerned that those patients who have suffered harm from taking Fosamax or another bisphosphonate drug might fail to protect their rights to seek compensation  to which they might be entitled.

The American Law Partners advises anyone with a friend or family member who has been prescribed Fosamax or another osteoporosis drug to recommend to that person that he or she consult a physician immediately, then speak to a qualified  Fosamax lawyer.   Affected individuals are advised to keep apprised of the latest news concerning the Fosamax femur fracture lawsuits by checking the Fosamax Femur Fracture Lawsuit Information Center for updated information. The site is equipped with easy-to-use social media features which will enable users to spread the word about the dangers of Fosamax.

Be Sociable, Share!